Xlife Sciences AG (XLS) | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Home
Companies
Xlife Sciences AG

BRIEF

published on 06/24/2025 at 18:05, 5 months 10 days ago

Xlife Sciences AG: General Meeting Success and Future Growth

Annual General Meeting Xlife Sciences AG U.S. Expansion Gene Therapies VERAXA Biotech
PRESS RELEASE

published on 06/24/2025 at 18:00, 5 months 10 days ago

Xlife Sciences AG: Successful General Meeting and Growth Prospects for 2025
Xlife Sciences AG's successful General Meeting approves all Board proposals and outlines growth prospects for 2025, including industry partnerships and international expansion

General Meeting International Expansion Partnerships Xlife Sciences AG Growth Prospects
BRIEF

published on 06/16/2025 at 16:05, 5 months 18 days ago

Xlife Sciences AG Enters Strategic Collaboration in Asia

Digital Health Precision Oncology AI-powered Solutions Strategic Collaboration Asia Expansion
PRESS RELEASE

published on 06/16/2025 at 16:00, 5 months 18 days ago

Strategic Collaboration Between Xlife Sciences AG, Huraypositive Corp., and OncoMASTER Inc. to Boost Digital Health and Precision Oncology in Asia
Xlife Sciences AG partners with Huraypositive Corp. and OncoMASTER Inc. to advance digital health and precision oncology in Asia through a strategic collaboration

Digital Health Precision Oncology Xlife Sciences AG Huraypositive Corp. OncoMASTER Inc.
BRIEF

published on 06/13/2025 at 17:47, 5 months 21 days ago

Strategic Alliance to Boost Korean Life Sciences Ventures' Global Reach

Innovation Life Sciences Global Markets Strategic Alliance IP Strategy
PRESS RELEASE

published on 06/13/2025 at 17:42, 5 months 21 days ago

Strategic Alliance Between Xlife Sciences AG, JIPYONG LLC and JIPYONG IP to Accelerate Korean Life Sciences Ventures’ Access to Global Capital Markets
Xlife Sciences AG partners with JIPYONG LLC and JIPYONG IP to boost Korean life sciences ventures' access to global capital markets. Strategic alliance to enhance global market positioning

Xlife Sciences AG Strategic Alliance JIPYONG LLC JIPYONG IP Korean Life Sciences
BRIEF

published on 05/06/2025 at 07:05, 6 months 29 days ago

Xlife Sciences Collaborates with Hovione for Gene Therapy in Liver Cancer

Strategic Partnership Gene Therapy Xlife Sciences Liver Cancer Hovione
PRESS RELEASE

published on 05/06/2025 at 07:00, 6 months 29 days ago

Xlife Sciences AG Announces Strategic Collaboration between Portfolio Company Firstgene Life Sciences and Hovione in the Field of Gene Therapy
Xlife Sciences AG announces strategic collaboration between Firstgene Life Sciences and Hovione in the field of Gene Therapy for Hepatocellular carcinoma treatment, expanding into gene therapy market

Partnership Gene Therapy Xlife Sciences AG Strategic Collaboration Hepatocellular Carcinoma
BRIEF

published on 05/05/2025 at 07:05, 6 months 30 days ago

Xlife Sciences AG Reports Sustainable Growth in 2024 Valuation

Portfolio Growth Strategic Expansion Xlife Sciences Valuation Report FUSE-AI Listing
PRESS RELEASE

published on 05/05/2025 at 07:00, 6 months 30 days ago

Xlife Sciences AG confirms sustainable value development and strategic scaling of the portfolio in the 2024 Valuation Report
Xlife Sciences AG confirms sustainable value development and strategic scaling of the portfolio in the 2024 Valuation Report. Key parameters include rNPV, cost of capital, and development risks

Xlife Sciences AG Financial Forecasts Strategic Plans Project Portfolio 2024 Valuation Report

Accesswire

Published on 12/05/2025 at 02:35, 3 hours 51 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 3 hours 56 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 5 hours 26 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 21 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 26 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 2 hours 56 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 35 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 1 minute ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 11 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 16 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 12 hours 26 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 41 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 42 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 25 minutes ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE